Deciding on umbilical cord blood stem cell and cord tissue stem cell preservation should be as simple for your patients as it is for your practice.
What is Cord Blood and Cryo-Cell’s Umbilical Cord Blood Service?
Umbilical cord blood is the blood that remains in the vein of the umbilical cord and placenta at the time of birth. Cord blood is rich in stem cells and Cryo-Cell’s service, collects, processes and cryogenically preserves these cells for potential medical use. Umbilical cord blood stem cells have been used to treat nearly 80 diseases with over 25,000 transplants worldwide.
What is Cord Tissue and Cryo-Cell’s Cord Tissue service?
Cryo-Cell proudly introduces our advanced new cord tissue service, which stores a section of the umbilical cord tissue. Cord tissue or Wharton’s jelly is the tissue surrounding the umbilical vein and vessels in the umbilical cord. Approximately six inches of the cord tissue is procured and transported to Cryo-Cell’s state-of-the-art laboratory for processing, testing and cryopreservation for potential future use. Umbilical cord tissue is a rich source of mesenchymal stem cells (MSCs). These stem cells have the capability to differentiate into bone cells, fat cells and cartilage, which are increasingly being utilized in regenerative medicine research, targeting potential therapies for a wide range of conditions including heart disease, stroke, multiple sclerosis and diabetes.
What are menstrual stem cells and what unique service does Cryo-Cell provide?
Cryo-Cell offers an exclusive and revolutionary service that provides women with the unique opportunity to collect and preserve vital stem cells that can be harvested from the body's menstrual fluid during the menstrual cycle. Until now, menstrual blood has typically been discarded as unsanitary waste. However, exciting new research shows that menstrual fluid contains self-renewing stem cells that can be easily collected, processed and cryo-preserved for potential cellular therapies that may emerge in the future. These menstrual stem cells come from the uterine lining (endometrium) that is shed as part of a woman’s menstrual period. These menstrual stem cells are unique because they have many properties and characteristics similar to both bone marrow and embryonic stem cells; they multiply rapidly and can differentiate into many other types of stem cells such as neural, cardiac, bone, fat, cartilage and possibly others; demonstrating great promise for future use in clinical regenerative medical therapies. Preliminary research suggests that in addition to potential use by the donor, these stem cells may possibly be used as well to benefit other family members who are genetically related to the donor, such as perhaps a parent, sibling or child.
The Cryo-Cell Difference
Cryo-Cell International, Inc. was founded in 1989 and was the world’s first private cord blood bank to separate and store stem cells in 1992. Today, Cryo-Cell has over 240,000 clients worldwide from 87 countries.
• Since inception, 100% of Cryo-Cell’s specimens have been successfully viable upon thaw.
• Accredited by AABB as a cord blood facility, AATB accredited, registered with the FDA, cGMP-/cGTP-compliant and ISO 9001:2008 certified.
Payment to Medical Professional for Umbilical Cord Blood and Cord Tissue Collection
Cryo-Cell provides physicians with a collection fee for services rendered in collecting cord blood, cord tissue, and menstrual blood. Each provider needs to complete and return a W-9 form, available here at http://www.irs.gov/pub/irs-pdf/fw9.pdf
to receive reimbursement.
Cryo-Cell’s umbilical cord tissue service provides expectant families with the opportunity to cryogenically store their newborn’s umbilical cord tissue cells contained within substantially intact cord tissue. Should umbilical cord tissue cells be considered for potential utilization in a future therapeutic application, further laboratory processing will be required.
In regards to umbilical cord tissue/menstrual stem cells, Cryo-Cell’s activities for New York State residents are limited to collection, processing, and long-term storage of umbilical cord tissue/menstrual stem cells. Cryo-Cell’s possession of a New York State license for such collection, processing and long-term storage does not indicate approval or endorsement of possible future uses or future suitability of these cells.